Abcam, ab251358, Anti-PMM1 antibody [EPR17844] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal PMM1 antibody. Carrier free. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 1 publication.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR17844,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat, Human,
Applications:WB, IHC-PSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab251358 is the carrier-free version of
ab202058
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The protein Phosphomannomutase 1 (PMM1) plays an essential role in carbohydrate metabolism by catalyzing the interconversion of mannose-6-phosphate and mannose-1-phosphate. The protein is also known as PMM-1 and has a molecular weight of approximately 28 kDa. PMM1 is expressed in various tissues including the liver kidney and muscle indicating its wide physiological relevance. Its enzymatic function is important for producing GDP-mannose which is necessary for glycosylation processes.
Biological function summary
PMM1 facilitates the conversion of mannose phosphates which is important in protein glycosylation pathways particularly in the synthesis of N-linked glycoproteins. PMM1 operates as a monomer and it does not form part of any larger enzymatic complex. Its activity ensures a proper supply of mannose-1-phosphate required for synthesizing GDP-mannose a donor substrate for glycosylation reactions that is critical in the production of structural molecules and signaling pathways.
Pathways
PMM1 plays a significant role in the biosynthesis of GDP-mannose and impacts the N-glycosylation pathway. PMM1's enzymatic activities integrate closely with glycosylation pathways interfacing with proteins involved in glycan assembly and modification. It interacts with other metabolic pathways that involve mannose and cooperatively influences the cellular processes for protein targeting and function through glycosylation alongside proteins like phosphomannose isomerase (PMI).
PMM1 mutations and dysregulation show potential links to congenital disorders of glycosylation (CDG). These disorders arise from improper glycosylation affecting a variety of bodily systems. PMM1's function and interaction with other glycosylating proteins such as PMM2 is critical in addressing the potential glycosylation defects that contribute to these rare genetic disorders. Although detailed studies are ongoing PMM1 remains a vital focus in understanding the molecular basis of these diseases and potentially developing therapeutic interventions.